Air dis-infection technology has become critical in hospitals, as mounting evidence demonstrates the limits of hand hygiene, surface cleaning, and protective gear such as masks, respirators, and gowns.
Novaerus portable air dis-infection devices use a non-selective, rapid killing, patented plasma technology, offering a unique and safe solution to kill airborne viruses 24/7. The technology has been independently tested to reduce MS2 Bacteriophage, a commonly used surrogate for SARS-CoV* (Coronavirus) by 99.99%.
Novaerus units operate continually and are safe around the most vulnerable patients, including Covid-19 patients in respiratory distress. A number of hospitals worldwide, including in Wuhan, China, have installed Novaerus portable units to help reduce transmission of SARS-CoV-2 among healthcare workers and patients.